Robert Alex "Rob" Szatkowski (born December 18, 1970), better known by his ring name Rob Van Dam (frequently abbreviated to RVD), is an American professional wrestler and occasional actor. He is best known for his appearances with Extreme Championship Wrestling (ECW) in the late 1990s, with the World Wrestling Federation/World Wrestling Entertainment (WWF/E) in the early to mid-2000s, and then with Total Nonstop Action Wrestling (TNA) in the early 2010s.
Between ECW, WWF/E and TNA Van Dam has won 21 total championships (including being a three-time world champion) and is the only wrestler in history to have held the WWE Championship, the ECW World Heavyweight Championship, and the TNA World Heavyweight Championship (including holding the WWE and ECW titles simultaneously within WWE). Van Dam is also the 2006 Money in the Bank winner, a WWE Triple Crown Champion, and a WWE Grand Slam Champion. Van Dam gained his mainstream popularity by 1998 when he won the ECW World Television Championship, which he held for a record 700 days. Between ECW, WWF/WWE, and TNA, Van Dam headlined major pay-per-view events in three decades between the 1990s, 2000s, and 2010s, closing the ECW's premier annual event November to Remember 1998. Van Dam is also a five time world tag team champion (two ECW, two WWE World Tag Team, and one WWE Tag Team). He is a six-time WWE Intercontinental Champion and was the final holder of the WWE Hardcore Championship and the last WWE European Champion, unifying both titles with his Intercontinental Championship. He is also a former TNA X Division Champion.
The abbreviation RVD may refer to:
Resolvins are dihydroxy or trihydroxy metabolites of the polyunsaturated omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) but also docosapentaenoic acid (DPA). These metabolites have been shown to be made by the cells and tissues of various animal species and humans. Resolvin (or Rv) metabolites of EPA are termed E resolvins (RvEs), those of DHA are termed D resolvins(RvDs), and those of DPA are termed resolvins D (RvDsn-3DPA) and resolvins T (RvTs) (RvDn-3DPA). The EPA-derived resolvins are nonclassic eicosanoids. Certain isomers of RvDs are termed aspirin-triggered resolvin Ds (AT-RvDs) because their synthesis is initiated by aspirin-acetylated COX2 to form 17(R)-hydroxy rather than the more classical 17(S)-hydroxy resolvins whose synthesis is initiated by lipoxygenases; however, an as yet unidentified cytochrome P450 enzyme(s) also forms this 17(R)-hydroxy intermediate and thereby contributes to the production of AT-RvDs. Resolvins are members of an expanding family of polyhydroxylated polyunsaturated fatty acid (PUFA) metabolites named "specialized pro-resolving mediators" (SPM). In addition to the resolvins, SPM include lipoxin, maresin, and protectin D1 (also termed neuroprotectin) metabolites of arachidonic acid (for lipoxins) or DHA (for maresins and protectins) as well as more recently defined and therefore less fully studied metabolites of the omega-3 PUFA isomer of DPA, 7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid (clupanodonic acid) and the metabolites of the N-acetylated fatty acid amide of the DHA metabolite, docosahexaenoyl ethanolamide. SPM form during the later stages of inflammatory responses, have various, often complementary anti-inflammatory, and are thought to be key mediators in resolving these responses. The putative anti-inflammatory effects of dietary omega-3 fatty acids such as fish oil, it is suggested, are due to the conversion of EPA, DHA, and/or DPA to resolvins.